Article Details

Does SCOTUS Chevron Decision Tip The Scales In Favor Of Industry? - Medtech Insight

Retrieved on: 2024-09-09 20:41:00

Tags for this article:

Click the tags to see associated articles and topics

Does SCOTUS Chevron Decision Tip The Scales In Favor Of Industry? - Medtech Insight. View article details on hiswai:

Summary

The article explains how the recent Supreme Court decision in Loper Bright Enterprises v. Raimondo overturns the Chevron doctrine, affecting regulatory authority over lab-developed tests (LDTs). This shift impacts MedTech regulation as courts no longer defer to FDA interpretations, potentially favoring industry challenges to FDA rules.

Article found on: medtech.citeline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up